AIHealthcare Analytics

Overview

Stanford HAI has published two complementary pieces of guidance addressing medical AI safety: a framework for building safe and secure medical AI platforms, and a methodology for operationalizing real-time monitoring of clinical AI post-deployment (Arts. 24, 44).

Safe and Secure Medical AI Platform

Stanford HAI's platform safety guidance addresses the architectural and governance requirements for medical AI systems, covering data security, model validation, access controls, audit logging, and incident response. The guidance is framed for developers and health system technology leaders rather than regulators, providing practical implementation standards.

Real-Time Monitoring

The real-time monitoring guidance addresses the recognized gap between premarket validation and post-deployment performance — a gap highlighted by the Nature Medicine benchmark study showing FDA-cleared AI may underperform general-purpose LLMs in real-world contexts. Stanford HAI's monitoring framework provides operational approaches for detecting model drift, performance degradation, and unexpected failure modes in deployed clinical AI systems.

Policy Relevance

Stanford HAI's dual guidance publications position the institution as a key standard-setter for clinical AI governance, operating in the space between FDA regulatory requirements (which address premarket approval) and health system operational needs (which require ongoing performance assurance). The FDA's separate call for input on real-world performance monitoring (Art. 95) suggests regulatory alignment with this approach may be forthcoming.